RESECTABLE PANCREATIC ADENOCARCINOMA
Clinical trials for RESECTABLE PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New chemo cocktail aims to shrink pancreatic tumors before surgery
Disease control Recruiting nowThis study tests whether giving a combination of three chemotherapy drugs (gemcitabine, cisplatin, and nab-paclitaxel) before surgery can help shrink pancreatic tumors and improve outcomes. It is for people with pancreatic cancer that can be removed or is borderline removable. Th…
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 10:34 UTC
-
New hope for pancreatic cancer: targeted pill may double time before relapse
Disease control Recruiting nowThis study tests whether a daily pill called olaparib can keep pancreatic cancer from returning after surgery and chemotherapy. It is for people whose tumors have specific gene changes (BRCA1, BRCA2, or PALB2). The goal is to see if olaparib can extend the time before the cancer …
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New triple attack on pancreatic cancer shows promise in early trial
Disease control Recruiting nowThis study is testing a new approach for people with pancreatic cancer that can be removed with surgery. Before surgery, patients receive a combination of chemotherapy, immunotherapy, and targeted radiation. After surgery, they continue with chemotherapy and immunotherapy. The go…
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Amsterdam UMC, location VUmc • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New study seeks clues to weight loss in pancreatic cancer patients
Knowledge-focused Recruiting nowThis study aims to learn why some people with pancreatic cancer lose weight and muscle (cachexia). Researchers will compare genes from tumor samples of 100 patients, focusing on differences between African Americans and other groups. The goal is to find patterns that could lead t…
Matched conditions: RESECTABLE PANCREATIC ADENOCARCINOMA
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated May 26, 2026 10:33 UTC